Robert S Wilson1, Sue E Leurgans, Patricia A Boyle, David A Bennett. 1. Rush Alzheimer's Disease Center, Department of Neurological Science, Rush University Medical Center, 600 S Paulina Ave, Ste 1038, Chicago, IL 60612, USA. rwilson@rush.edu
Abstract
OBJECTIVE: To characterize the course of cognitive decline during the prodromal phase of Alzheimer disease. DESIGN: Longitudinal cohort study with up to 16 years of observation. PARTICIPANTS: Older persons from 2 studies underwent annual clinical evaluations that included cognitive function testing and clinical classification of mild cognitive impairment, dementia, and Alzheimer disease. At baseline, there were 2071 individuals without dementia and 1511 without cognitive impairment. RESULTS: During follow-up, 462 persons developed Alzheimer disease (20 with dementia solely due to another condition were excluded). Five to six years before diagnosis, the rate of global cognitive decline accelerated more than 15-fold. The acceleration in cognitive decline occurred slightly earlier for semantic memory (76 months before diagnosis) and working memory (75 months) than other cognitive functions. Mild cognitive impairment was also preceded by years of cognitive decline that began earlier (80 months before diagnosis) and proceeded more rapidly (annual loss of 0.102 unit) in the amnestic than in the nonamnestic (62 months, 0.072 unit) subtype. CONCLUSION: Dementia due to Alzheimer disease is preceded by about 5 to 6 years of accelerated decline in multiple cognitive functions. By contrast, little decline is evident in persons who do not develop Alzheimer disease.
OBJECTIVE: To characterize the course of cognitive decline during the prodromal phase of Alzheimer disease. DESIGN: Longitudinal cohort study with up to 16 years of observation. PARTICIPANTS: Older persons from 2 studies underwent annual clinical evaluations that included cognitive function testing and clinical classification of mild cognitive impairment, dementia, and Alzheimer disease. At baseline, there were 2071 individuals without dementia and 1511 without cognitive impairment. RESULTS: During follow-up, 462 persons developed Alzheimer disease (20 with dementia solely due to another condition were excluded). Five to six years before diagnosis, the rate of global cognitive decline accelerated more than 15-fold. The acceleration in cognitive decline occurred slightly earlier for semantic memory (76 months before diagnosis) and working memory (75 months) than other cognitive functions. Mild cognitive impairment was also preceded by years of cognitive decline that began earlier (80 months before diagnosis) and proceeded more rapidly (annual loss of 0.102 unit) in the amnestic than in the nonamnestic (62 months, 0.072 unit) subtype. CONCLUSION:Dementia due to Alzheimer disease is preceded by about 5 to 6 years of accelerated decline in multiple cognitive functions. By contrast, little decline is evident in persons who do not develop Alzheimer disease.
Authors: R J Killiany; B T Hyman; T Gomez-Isla; M B Moss; R Kikinis; F Jolesz; R Tanzi; K Jones; M S Albert Journal: Neurology Date: 2002-04-23 Impact factor: 9.910
Authors: Neelum T Aggarwal; Robert S Wilson; Julia L Bienias; Philip L De Jager; David A Bennett; Denis A Evans; Charles DeCarli Journal: Arch Neurol Date: 2010-04
Authors: Philip D Sloane; Sheryl Zimmerman; Chirayath Suchindran; Peter Reed; Lily Wang; Malaz Boustani; S Sudha Journal: Annu Rev Public Health Date: 2001-10-25 Impact factor: 21.981
Authors: R S Wilson; L L Barnes; N T Aggarwal; P A Boyle; L E Hebert; C F Mendes de Leon; D A Evans Journal: Neurology Date: 2010-09-01 Impact factor: 9.910
Authors: D A Bennett; R S Wilson; J A Schneider; D A Evans; L A Beckett; N T Aggarwal; L L Barnes; J H Fox; J Bach Journal: Neurology Date: 2002-07-23 Impact factor: 9.910
Authors: Robert S Wilson; Laurel A Beckett; Lisa L Barnes; Julie A Schneider; Julie Bach; Denis A Evans; David A Bennett Journal: Psychol Aging Date: 2002-06
Authors: Carrie E Bearden; Katherine H Karlsgodt; Peter Bachman; Theo G M van Erp; Anderson M Winkler; David C Glahn Journal: Neuroscientist Date: 2011-08-10 Impact factor: 7.519
Authors: Napatkamon Ayutyanont; Jessica B S Langbaum; Suzanne B Hendrix; Kewei Chen; Adam S Fleisher; Michel Friesenhahn; Michael Ward; Camilo Aguirre; Natalia Acosta-Baena; Lucìa Madrigal; Claudia Muñoz; Victoria Tirado; Sonia Moreno; Pierre N Tariot; Francisco Lopera; Eric M Reiman Journal: J Clin Psychiatry Date: 2014-06 Impact factor: 4.384
Authors: Mary M Machulda; V Shane Pankratz; Teresa J Christianson; Robert J Ivnik; Michelle M Mielke; Rosebud O Roberts; David S Knopman; Bradley F Boeve; Ronald C Petersen Journal: Clin Neuropsychol Date: 2013-09-17 Impact factor: 3.535
Authors: Aaron Reuben; Maxwell L Elliott; Wickliffe C Abraham; Jonathan Broadbent; Renate M Houts; David Ireland; Annchen R Knodt; Richie Poulton; Sandhya Ramrakha; Ahmad R Hariri; Avshalom Caspi; Terrie E Moffitt Journal: JAMA Date: 2020-11-17 Impact factor: 56.272